Latin America Anti-venom Market Size & Outlook, 2023-2030
The anti-venom market in Latin America is expected to reach a projected revenue of US$ 120.5 million by 2030. A compound annual growth rate of 7.3% is expected of Latin America anti-venom market from 2024 to 2030.
Revenue, 2023 (US$M)
$73.5
Forecast, 2030 (US$M)
$120.5
CAGR, 2024 - 2030
7.3%
Report Coverage
Latin America
Latin America anti-venom market, 2018-2030 (US$M)
Latin America anti-venom market highlights
- The Latin America anti-venom market generated a revenue of USD 73.5 million in 2023.
- The market is expected to grow at a CAGR of 7.3% from 2024 to 2030.
- In terms of segment, snake was the largest revenue generating species in 2023.
- Snake is the most lucrative species segment registering the fastest growth during the forecast period.
Latin America data book summary
| Market revenue in 2023 | USD 73.5 million |
| Market revenue in 2030 | USD 120.5 million |
| Growth rate | 7.3% (CAGR from 2023 to 2030) |
| Largest segment | Snake |
| Fastest growing segment | Snake |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Snake |
| Key market players worldwide | Bristol-Myers Squibb Co, Celgene, Eisai Co Ltd, Phaxiam, Roche Holding AG, Genmab A/S, GlaxoSmithKline, Novartis AG ADR, Pfizer Inc, Sanofi SA |
Other key industry trends
- In terms of revenue, Latin America region accounted for 6.2% of the global anti-venom market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 507.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anti-Venom Market Scope
Anti-venom market segmentation & scope
Type
Polyvalent
Monovalent
Mode of Action
Cytotoxic
Neurotoxic
Haemotoxic
Cardiotoxic
Myotoxic
Others
End Use
Hospitals
Clinics
Ambulatory Surgical Centers
Countries
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
Anti-Venom Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America anti-venom market
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
